Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer

$5.85M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	University of Pittsburgh At Pittsburgh
Country	United States
Start Date	Feb 03, 2021
End Date	Jan 31, 2026
Duration	1,823 days
Number of Grantees	3
Roles	Co-Investigator; Principal Investigator
Data Source	NIH (US)
Grant ID	`10770394`

Grant Description

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, primarily due to most cases being diagnosed at an advanced, incurable stage. While 5-year survival of metastatic PDAC is